Skip to content
FDA drug shortage status

Is Pentostatin Injection (Nipent) in shortage?

Yes. Pentostatin Injection is on FDA’s drug shortage list (unavailable), last updated Aug 27, 2026.

In shortageFDA status
1packages listed
1unavailable

Why it’s in shortage

  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Aug 27, 2026

    Next delivery: Q2 2027; Estimated recovery: Q3 2027; Shortage per manufacturer: manufacturing delays

    Maker contact: 844-646-4398

Pentostatin Injection shortage questions

Is Pentostatin Injection (Nipent) in shortage?

Yes. Pentostatin Injection is on FDA’s drug shortage list (unavailable), last updated Aug 27, 2026.

Why is there a Pentostatin Injection shortage?

FDA records the reason as: Other.

What should I do if I can’t get Pentostatin Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.